# Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome

> **NCT06342999** · NA · ENROLLING_BY_INVITATION · sponsor: **Mauro H. Schenone** · enrollment: 80 (estimated)

## Conditions studied

- Hypoplastic Left Heart Syndrome

## Interventions

- **PROCEDURE:** Fetal Aortic Valvuloplasty Procedure
- **DEVICE:** Emerge Monorail and Over-The-Wire PTCA Dilatation Catheter
- **DEVICE:** Trek RX and Mini Trek RX Coronary Dilatation Catheter

## Key facts

- **NCT ID:** NCT06342999
- **Lead sponsor:** Mauro H. Schenone
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2027-01-01
- **Primary completion:** 2036-07
- **Final completion:** 2036-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06342999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06342999, "Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06342999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*